NCT06860919 Prospective Evaluation of the Results of Multidisciplinary Follow-up After a Transitional Consultation for Esophageal Atresia
| NCT ID | NCT06860919 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Esophageal Atresia |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-12-19 |
| Primary Completion | 2030-12-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-12-19 with a primary completion date of 2030-12-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A transition consultation for adult patients with esophageal atresia, involving medical and paramedical stakeholders, was set up at Hôpital Saint-Louis in 2020. The aim of this initiative is to: 1. initiate adult medical, psychological and social follow-up; 2. empower these adults in their future care; 3. establish a personalized follow-up schedule. This project is the first to focus on post-traumatic stress disorder (PTSD) in young adults with esophageal atresia. A 3-year analysis of the somatic and psychosocial variables analyzed will confirm the validity of this initiative, and define its optimal contours for improving these patients' quality of life as adults.
Eligibility Criteria
Inclusion Criteria: * Patients with esophageal atresia * Aged 18 to 30 * Followed at Hôpital Saint Louis * Informed and not opposed to the study * Patients affiliated to a social security scheme Exclusion Criteria: * Inability to answer questionnaires * Patients under guardianship * Patients under AME (Aide Médicale d'Etat in France)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06860919 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Esophageal Atresia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06860919 currently recruiting?
Yes, NCT06860919 is actively recruiting participants. Contact the research team at pierre.cattan@aphp.fr for enrollment information.
Where is the NCT06860919 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06860919 clinical trial?
NCT06860919 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 50 participants.